Zacks Research Brokers Boost Earnings Estimates for THC

Tenet Healthcare Corporation (NYSE:THC) – Zacks Research increased their Q3 2026 earnings per share (EPS) estimates for Tenet Healthcare in a note issued to investors on Thursday, August 13th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $4.34 for the quarter, up from their previous forecast of $4.13. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Tenet Healthcare’s current full-year earnings is $21.07 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q1 2027 earnings at $4.63 EPS and Q1 2028 earnings at $4.52 EPS.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.26 by $1.86. The company had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm’s revenue was up 6.8% compared to the same quarter last year. During the same period last year, the business posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS.

Several other equities analysts have also issued reports on the company. Raymond James Financial set a $270.00 price target on Tenet Healthcare in a research note on Monday, July 27th. Barclays raised their price objective on shares of Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a report on Friday, July 24th. Weiss Ratings cut Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 2nd. The Goldman Sachs Group reiterated a “buy” rating and issued a $305.00 target price on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Finally, Robert W. Baird increased their target price on Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a report on Tuesday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $272.25.

Tenet Healthcare Trading Up 0.2%

Shares of THC stock opened at $267.40 on Friday. The firm’s fifty day simple moving average is $208.09 and its 200 day simple moving average is $203.48. The firm has a market capitalization of $21.53 billion, a P/E ratio of 10.31, a price-to-earnings-growth ratio of 1.02 and a beta of 1.23. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. Tenet Healthcare has a 1 year low of $157.58 and a 1 year high of $270.57.

Insider Activity at Tenet Healthcare

In related news, Director Christopher S. Lynch sold 3,837 shares of the stock in a transaction that occurred on Monday, July 27th. The stock was sold at an average price of $243.44, for a total transaction of $934,079.28. Following the completion of the sale, the director directly owned 9,568 shares of the company’s stock, valued at approximately $2,329,233.92. This represents a 28.62% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Paola M. Arbour sold 10,878 shares of the business’s stock in a transaction dated Monday, July 27th. The shares were sold at an average price of $243.90, for a total value of $2,653,144.20. Following the completion of the sale, the executive vice president owned 18,413 shares in the company, valued at approximately $4,490,930.70. This trade represents a 37.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 41,375 shares of company stock valued at $9,793,347 over the last 90 days. Insiders own 0.97% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Triumph Capital Management bought a new position in Tenet Healthcare during the 3rd quarter worth $25,000. Activest Wealth Management bought a new stake in shares of Tenet Healthcare during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new position in shares of Tenet Healthcare during the fourth quarter worth $29,000. Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare in the second quarter valued at $35,000. Finally, Trust Co. of Vermont acquired a new stake in shares of Tenet Healthcare in the second quarter valued at about $37,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.